PharmGKB summary: very important pharmacogene information for ABCG2.

about

PharmGKB summary: very important pharmacogene information for ABCG2.

Item

http://www.wikidata.org/entity/Q46018199

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

PharmGKB summary: very important pharmacogene information for ABCG2.

@en

PharmGKB summary: very important pharmacogene information for ABCG2.

@nl

type

Item

label

PharmGKB summary: very important pharmacogene information for ABCG2.

@en

PharmGKB summary: very important pharmacogene information for ABCG2.

@nl

prefLabel

PharmGKB summary: very important pharmacogene information for ABCG2.

@en

PharmGKB summary: very important pharmacogene information for ABCG2.

@nl

P1476

PharmGKB summary: very important pharmacogene information for ABCG2.

@en

P2093

Alison E Fohner

http://www.w3.org/2001/XMLSchema#string

Deanna J Brackman

http://www.w3.org/2001/XMLSchema#string

Kathleen M Giacomini

http://www.w3.org/2001/XMLSchema#string

Teri E Klein

http://www.w3.org/2001/XMLSchema#string

P2860

ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion

The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing

Analysis of protein-coding genetic variation in 60,706 humans

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies

ABCG2: the molecular mechanisms of urate secretion and gout

Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction

The Genotype-Tissue Expression (GTEx) project

Membrane transporters in drug development

P304

420-427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/FPC.0000000000000305

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Russ Altman

P577

2017-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28858993

http://www.w3.org/2001/XMLSchema#string

P932

5788016

http://www.w3.org/2001/XMLSchema#string